Royalty Pharma
RPRX
RPRX
134 hedge funds and large institutions have $6.52B invested in Royalty Pharma in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 39 closing their positions.
Holders
134
Holders Change
+11
Holders Change %
+8.94%
% of All Funds
2.71%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
50
Increased
47
Reduced
18
Closed
39
Calls
$5.21M
Puts
$6.43M
Net Calls
-$1.22M
Net Calls Change
-$2.3M
Top Buyers
Top Sellers
| 1 |
1
Norges Bank
Oslo,
Norway
|
$30.4M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$2.84M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$26.1M |
| 4 |
4
Viking Global Investors
Stamford,
Connecticut
|
$82M |
| 5 |
AG
5
Artal Group
Luxembourg
|
$10.5M |
